Akumentis Healthcare Ltd
Letrozole (2.5mg)
Clomipure-L Tablet is used to treat breast cancer in post-menopausal women, either alone or with other treatments, and to stop the tumor from spreading to other parts of the body.
Tablet
Clomipure-L Tablet is an aromatase inhibitor that helps treat breast cancer in post-menopausal women. It works by decreasing the amount of estrogen produced in the body, which can slow down or stop the growth of some breast cancers that need estrogen to grow. It may be used alone or with other treatments, such as surgery or radiation.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. It may be taken with or without food, but it is better to take it at a fixed time.
Clomipure-L Tablet is an aromatase inhibitor that works by decreasing the amount of estrogen produced in the body. This decrease in estrogen can slow down or stop the growth of some breast cancers that need estrogen to grow.
You have been prescribed Clomipure-L Tablet for the treatment of breast cancer. It can be taken with or without food. Do not drive or do anything requiring concentration until you know how Clomipure-L Tablet affects you. It may cause increased sweating and hot flushes. Try to keep cool by wearing light and airy clothes. Your doctor may monitor your cholesterol level and bone mineral density (BMD) regularly as Clomipure-L Tablet can alter their levels.
Clomipure-L Tablet is an aromatase inhibitor. It is generally prescribed to treat breast cancer in women who no longer have periods, either due to menopause or after surgery or chemotherapy.
Clomipure-L Tablet is also known as an anti-estrogen drug. It is called so because it acts by reducing the production of estrogen in your body by blocking the enzyme aromatase, which is responsible for the production of estrogen. Estrogen stimulates the production of certain types of breast cancer in your body. These cancers are called "estrogen-dependent cancers". Reducing the production of estrogen may prevent cancer from growing.
If the breast tumor is in the advanced stage or has spread to other parts of the body, it is recommended that you continue taking Clomipure-L Tablet till the tumor shows progression. In cases where Clomipure-L Tablet is given after tamoxifen (another anti-estrogen used for breast cancer) or surgery, it should be given for 5 years or until the tumor comes back, whichever is first. It can also be given as a sequential treatment; 2 years of Clomipure-L Tablet followed by 3 years of tamoxifen.
Yes, you can take irbesartan and Clomipure-L Tablet together. However, be careful and keep a regular check on your blood pressure since Clomipure-L Tablet may increase your blood pressure. Consult your doctor in case you have problems controlling your blood pressure.
Although it is very uncommon, Clomipure-L Tablet may cause a cataract. So, if you experience blurred vision or eye irritation, consult your doctor immediately.
This could be a sign of hot flushes which is a very common side effect of Clomipure-L Tablet. It happens due to decreased estrogen levels. The frequency of hot flushes reduces once your body adjusts to Clomipure-L Tablet. However, in some people, the flushes and sweats may continue during the treatment and stop a few months after the treatment finishes. You can consult your doctor who will provide you a remedy if it is very bothersome.
The serious side effects do not occur in everyone and very few people experience them. The serious side effects of Clomipure-L Tablet include stroke, angina, heart attack, blood clotting, cataract, osteoporosis, and severe skin reactions.
Clomipure-L Tablet may cause thinning or wasting of your bones (osteoporosis), which is due to the decrease in estrogen levels in your body. Your doctor may decide to measure your bone density (a way of monitoring for osteoporosis) before, during and after treatment.
As per the Ministry of Health and Family Welfare, Clomipure-L Tablet is restricted for use in induction of ovulation in anovulatory infertility.